Dihexa

Research Goal: Analyzing the potential for cognitive enhancement and synaptic repair in neurodegenerative models.

Route

Topical application

Dose range

5 mg – 20 mg

Frequency

Once per day or every other day

Cycle length

4–8 weeks

Not currently stocked by N1 Aminos. Browse what is in stock →

Overview

Research Goal: Analyzing the potential for cognitive enhancement and synaptic repair in neurodegenerative models.

Preparation: Can be administered orally (in DMSO or ethanol solution) or topically (transdermal). Note: Subcutaneous use is less common due to solubility.

Studied benefits

  • A potent neurogenic peptide designed to improve cognitive function and repair brain damage
  • It is studied for its ability to enhance synaptic connectivity and potentially reverse memory loss in neurodegenerative conditions

Reported side effects

  • Human data is sparse
  • Preclinical studies suggest it is well-tolerated, though potential risks of over-stimulating certain growth factors are still being researched

Protocol

Dosing Schedule (Oral/Transdermal)

Educational reference only. Not medical advice. Research compounds are not approved for human use. Full disclaimer.

Dosage TierDaily Dose (mg)MethodLog
Low Dose5 mgTransdermal/Oral+ Log
Standard Research10–20 mgTransdermal/Oral+ Log

Frequency

Once per day or every other day.

Timing

Morning administration to monitor cognitive alertness.

Cycle length

4–8 weeks.

Context

Lifestyle considerations

Prioritize a diet rich in Omega-3 fatty acids, choline, and antioxidants to provide the necessary "brain fuel" for the synaptogenesis (new brain cell connections) stimulated by this peptide. Engage in daily cognitive challenges, such as learning a new language, reading, or complex problem-solving, to guide the newly formed neural pathways toward meaningful functional use. Ensure 7–9 hours of quality sleep for memory consolidation and to allow the glymphatic system to clear metabolic waste from the brain. Avoid alcohol and neurotoxic substances, which can impair the peptide's significant potential for cognitive enhancement.

Evidence

Research summaries

Dihexa's Therapeutic Potential in Synaptic Connectivity for Cognitive Disorders

Findings: Grows new brain links for better memory and learning, heals Alzheimer's-like fog, boosts thinking speed.

Brains connect thoughts via synapses—like phone wires between brain cities. In Alzheimer's or injury, wires snap, forgetting names or skills. Dihexa, a small peptide, supercharges growth factor HGF/c-Met to build and strengthen these wires fast—7x better than brain fertilizer BDNF in lab neuron tests. Rats with cut brain paths or old age mush learned mazes quicker, remembered longer. It sparks PI3K/Akt and ERK paths for new connections without messing dopamine directly. For students with foggy study sessions or post-concussion blues, it means sharper recall for tests, faster puzzle-solving, steady focus in class. No neurotransmitter chaos—just pure rewiring. Promising for family dementia worries too, turning weak circuits mighty. Safe trophic remodel, like upgrading brain highways for traffic-free thinking.

Read the study ↗

Dihexa Facilitates Memory Consolidation and Retrieval via Neurotrophic Signaling

Findings: Strengthens learning circuits, aids recovery from brain trauma, enhances neuroplasticity for new skills.

Learning sticks when synapses toughen post-lesson. Dihexa locks them by stabilizing new grows, helping rats stash/replay memories better. Activates survival paths in stressed neurons, great for stroke or hit recovery. Teens master math or sports moves easier, brains adapt to changes like new schools. Indirect dopamine/serotonin perks from healthier nets.

Read the study ↗

Dihexa in Alzheimer's Models: Synaptogenesis and Cognitive Enhancement

Findings: Reverses memory loss, promotes neuron survival, potential for daily brain boost.

Fades foggy recall? Dihexa rebuilds synapse webs, outperforming rivals in plaque-heavy brains. Survival signals protect during remodel. School smarts soar.

Read the study ↗
More references (6)

Identification

Chemistry

cas
1401708-83-5
formula
C₂₇H₄₄N₄O₅
molecular weight
504.66 g/mol (also reported as 504.7 g/mol)
sequence
Core tripeptide sequence Tyr-Ile-X (where X represents the modified C-terminal structure); N-terminal hexanoyl modification added to the tyrosine residue
source
Synthetic; derived from angiotensin IV (a naturally occurring brain peptide) with engineered structural modifications
biosynthesis
Non-ribosomal; chemically synthesized peptide
type
Linear peptide with N-terminal hexanoyl and C-terminal 6-aminohexanoic acid modifications

Keep exploring

Related peptides

Educational use only. The protocols shown summarise published research and community practice for informational purposes. They are not medical advice, not a prescription, and not a recommendation to use any compound. Research peptides are generally not approved for human use. Consult a licensed clinician. Full disclaimer.
Ask the advisor